Overview

FredandBrent-RDL2016

Fred Hassan, Managing Director, Warburg Pincus with Brent Saunders, CEO and President, Allergan

Each year, the Conference Forum holds a private event for heads of R&D from pharma and biotech companies. The attendees explore different routes to higher productivity with a careful look at options and creative solutions on cost, speed and decision-making. The R&D Leadership Summit addresses some of the biggest questions and challenges for senior level R&D executive management. The 2016 theme was dedicated to sources of innovation.

We were delighted to have David Nicholson, PhD, EVP, Global Brands R&D, Allergan and Deborah Dunsire, MD, CEO, Forum Pharmaceuticals as co-chairs and Fred Hassan, Partner, Warburg Pincus as the opening keynote presenter. We are grateful to the guidance of Dr Thomas Koestler, Executive Director Health Care, Vatera Health Care Partners.

We are pleased to announce that the 2016 keynotes included Elias Zerhouni, MD, President, Global R&D, Sanofi, Patrick Vallance, MD, President Pharmaceuticals R&D, GSK, Jay Siegel, MD, Chief Biotechnology Officer and Head, Scientific Strategy and Policy, Johnson & Johnson, Bahija Jallal, MD, EVP, MedImmuneLars Rebien Sorensen, CEO, Novo Nordisk,  David Epstein, MBA, Division Head, Novartis and Brent Saunders, MBA, CEO and President, Allergen.

RDL-collage-2016-2The program has expanded to include more R&D heads from emerging biotechs and the life science investment community. Many thanks to the entire speaking faculty who bring their vast experience together to share their vision and strategy in:

  • Creating & Capturing the Value of Innovation
  • Competing R&D Philosophies on Culture and Leadership
  • How is Money being Invested in R&D?
  • Improving R&D Productivity
  • Portfolio Management
  • Innovation
  • Talent
  • Pricing
  • Value, Coverage and Reimbursement
  • Regulatory Approval and Market Access Management
  • New FDA Initiatives
  • Patient Centricity Impact on R&D Strategy
  • Outsourcing
  • R&D Leadership at Venture Backed Bio Pharma
  • and more
Bahija2men - RDL2016

Dr Bahija Jallal, EVP , MedImmune, Genghis Lloyd-Harris, Partner, Abingworth & Francesco De Rubertis, Partner Medicxi Ventures

The format of the conference is a combination of presentations, interviews and panel discussions. The Summit provides plenty of networking opportunities, including breakfast, luncheons, welcome reception, dinner and networking breaks.

The R&D Leadership Summit is open only to senior level R&D executives from clinical stage pharmaceutical, biotech, medical device and vaccine companies.

Our audience is as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change to advance R&D and to provide support for the leaders behind the movement. If you are interested in joining the 2017 Summit, please contact me at Valerie@tcfllc.org or my colleague Jennifer Moran at Jennifer@tcfllc.org. As the Summit is a private, by invitation only event, seating is limited.

Sincerely,

Valerie Bowling New

 

Valerie Bowling
Executive Director
R&D Leadership Summit

 

Meredith Sands B&W

 

Meredith Sands
Executive Director, Business Development
R&D Leadership Summit

 


Testimonials

  • "I thoroughly enjoyed the sessions and the opportunity to interact with many difference leaders in the industry at the R&D Leadership Summit."

    - Deborah Dunshire, FORUM Pharmaceuticals